eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 01/08/2008
SPC Calamine Lotion BP (Boots Company PLC)


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Calamine Lotion BP


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredients

% w/v

Calamine BP

15

Zinc Oxide Ph Eur

5


Go to top of the page
3. PHARMACEUTICAL FORM

Lotion


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the relief of minor skin rashes and irritation.


Go to top of the page
4.2 Posology and method of administration

Adults, children and elderly

To be applied when required to the affected area.

For topical application.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Shake the bottle.

For external use only.

Keep all medicines out of the reach of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.


Go to top of the page
4.6 Pregnancy and lactation

The safety of Calamine Lotion during pregnancy and lactation has not been established but use during these periods is not considered to constitute a hazard.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

Occasional hypersensitivity or irritant reactions.


Go to top of the page
4.9 Overdose

If ingested symptoms of overdosage include anorexia, nausea, vomiting, epigastric discomfort and diarrhoea. Treatment consists of symptomatic measures only.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Calamine has a mild astringent action on the skin.


Go to top of the page
5.2 Pharmacokinetic properties

None known.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Bentonite

Glycerol

Sodium Citrate

Phenol

Water Purified


Go to top of the page
6.2 Incompatibilities

None stated.


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

None.


Go to top of the page
6.5 Nature and contents of container

A white flint glass bottle with an unlined polypropylene cap.

An amber glass bottle with vinyl seal faced compocork in thermoset plastic cap.

Alternative cap: Aluminium roll-on pilfer-proof cap with a flowed in liner or a triseal (LDPE/EPE/LDPE) liner.

Pack sizes: 200, 2000 millilitres


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

Trading as: BCM


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/5471R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Date of First Authorisation: 31 October 1984

Date of Last Renewal: 23 January 1996


Go to top of the page
10. DATE OF REVISION OF THE TEXT

February 2007



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/8409/SPC/


Active Ingredients/Generics

 
   zinc oxide
   calamine